Efficient Hammerhead Ribozymes Targeted to the Polycistronic Sendai Virus P/C mRNA
STRUCTURE-FUNCTION RELATIONSHIPS*

(Received for publication, August 1, 1996, and in revised form, November 2, 1996)

Denise K. Gavin Dagger § and Kailash C. Gupta

From the Department of Immunology/Microbiology, Rush Medical College, Chicago, Illinois 60612

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The Sendai virus polycistronic P/C mRNA encodes the P and C proteins from alternate overlapping reading frames. To determine the functions of these proteins in virus replication, hammerhead ribozymes were targeted to cleave the 5'-untranslated region of the P/C mRNA. Both cell-free and intracellular assays were employed to determine ribozyme efficacy. To appropriately compare activities between cell-free and intracellular assays, identical ribozymes were synthesized in vitro as well as expressed in cells. Ribozyme parameters, namely hybridization arm length (HAL) and nonhybridizing extraneous sequences (NES), were found to have rate-determining properties. In cell-free reactions, ribozymes with 13-mer HAL were up to 10-fold more efficient than those with 9-mer HAL. Ribozymes with 9-mer HAL were relatively ineffective in transfected cells. Minimizing the number of NES increased ribozyme efficiency in vitro. However, ribozymes with minimal NES were essentially inert intracellularly. The NES at the termini of the most effective intracellular ribozyme, Rz13st (~95% inhibition of the p gene expression), were predicted to fold into stem-loop structures. These structures most likely increase ribozyme stability as evidenced by the 8-fold higher resistance to ribonuclease T2 digestion of Rz13st compared with Rz13B. Our results suggest that when designing effective intracellular ribozymes, parameters that enhance formation of productive ribozyme:substrate duplexes and that increase RNA stability should be optimized.


INTRODUCTION

Sendai virus is a prototypic paramyxovirus that replicates exclusively in the cytoplasm. The single strand negative-sense RNA genome of the Sendai virus encodes at least six genes, np, p, m, f, hn, and l (1). The p gene is transcribed into two polycistronic mRNAs, P/C and V/C (2). The polycistronic P/C mRNA is translated to synthesize the P, C, C', Y1, and Y2 proteins from independent start sites in two overlapping reading frames. Although the C protein is expressed at levels comparable with P in infected cells (3), it is a minor component of virions (4). The other proteins, C', Y1, and Y2 are expressed at relatively low levels in virus-infected cells (3). Although the P protein is required for viral transcription and replication (1, 5), the functional significance of the C proteins is not precisely defined. A recent study has suggested that the C protein may be involved in the regulation of viral transcription (6). To define further the functions of the P and C proteins, we have developed ribozymes to block the P/C mRNA expression in virus-infected cells.

Ribozymes are RNA molecules with self-cleaving enzymatic activities (7, 8). Ribozymes can be designed to act in trans to specifically cleave virtually any RNA molecule (9), making them particularly attractive as antiviral agents (10-14) and as tools for studying gene function (15, 16). However, the factors that influence ribozyme and substrate interactions in vivo are not well defined. In many in vivo studies, very high ribozyme:substrate ratios were necessary to detect ribozyme activity (17-20). Ribozymes to be used intracellularly are generally optimized using cell-free cleavage assays. Considerable disparity appears to exist between in vitro kinetics and intracellular activity (18, 19). This could be due to differential intracellular structural properties of the ribozyme and/or substrate and/or to RNA-protein interactions. These discrepancies reflect that in vitro kinetics are frequently determined with synthetic model ribozymes that do not accurately represent the ribozymes that would be synthesized in vivo from expression vectors. Ribozymes expressed intracellularly from expression vectors contain modifications to their basic structure due to the incorporation of vector sequences. These changes may influence appropriate folding and thus inherently affect activity. Consequently, cell free kinetics would be more predictive of intracellular ribozyme activity if they were performed with RNA transcripts containing comparable structural elements as those synthesized intracellularly.

In the present study, we compared the cell-free and intracellular activities of several hammerhead-type ribozymes to develop the most effective intracellular ribozymes targeted to the Sendai virus P/C mRNA. Ribozymes were designed such that their in vitro and in vivo structural elements would be essentially identical. We examined the influence of parameters effecting ribozyme-substrate interactions, namely hybridization arm length (HAL)1 and nonhybridizing extraneous sequences (NES) on ribozyme activity. Manipulating these parameters, we generated ribozymes that inhibited p/c gene expression by nearly 95% in transiently transfected cells at a low ribozyme:substrate molar ratio. These results indicate that the ribozyme strategy is amenable for studying the function of p gene encoded proteins. Moreover, our study shows that efficient ribozymes can be expressed intracellularly by manipulating their structural features.


MATERIALS AND METHODS

Construction of Plasmids

All recombinant DNA manipulations were performed following standard techniques (21). Sense and antisense ribozyme plasmid constructs, pcRz1 and pcRz2 (Fig. 2A), respectively, were generated from two synthetic complementary oligodeoxynucleotides (oligonucleotides, Table I). The oligonucleotides contained the 22-nucleotide (nt) catalytic region from the satellite RNA of the tobacco ring spot virus (sTobRSV) (22), flanked on either side by 13 nt complementary to the 5'-UTR of the P/C mRNA (between nt 58-70 and 72-84) (Fig. 1A). BamHI sites (Table I) were designed at the termini of the duplex for cloning into the BamHI site of the eukaryotic expression vector, pcDNAI/amp (Invitrogen). Equivalent amounts of complementary oligonucleotides were mixed, heated to 95 °C for 3 min, and annealed by slowly cooling to room temperature. Annealed oligonucleotides (duplexes) were then digested with BamHI, phenol/chloroform extracted, ethanol-precipitated, and ligated to the BamHI-digested and alkaline phosphatase-treated pcDNAI/amp.


Fig. 2. Schematic presentation of ribozyme constructs (pcRzs). A, Rz1 (sense) and Rz2 (antisense) were cloned into the BamHI (B) site of pcDNAI/amp (Invitrogen). These constructs are derived from the same pair of oligonucleotides (Table I) except that they carry opposite orientations of the duplex. B, Rz9, Rz13, and anti-PC oligonucleotides (Table I) were cloned into the HindIII (H) and B sites of pcDNAI/amp. Restriction sites used for cloning and linearization are indicated. C, pcRz13st, pcRz9st, and pcanti-PCst were derived from pcRz13, pcRZ9, and pcanti-PC by inserting sRz and tT cassettes downstream of the ribozyme or antisense sequences. sRz represents a self-cleaving hammerhead ribozyme cassette derived from sTobRSV, and tT represents the termination sequences for T7 RNA polymerase. D, construct used to transcribe the substrate in vitro and express the Sendai virus P/C mRNA in cells. Lengths of the 5'-nonhybridizing extraneous sequences (NES) present on the transcripts are shown as 17* and 35* nt. Lengths of the 3'-NES of transcripts are indicated in parentheses as B = 1, E = 31, sRz = 17, and tT = 123 (if the sRz does not cleave). CMV and T7 represent the cytomegalovirus immediate-early enhancer/promoter region and the bacteriophage T7 promoter, respectively.
[View Larger Version of this Image (28K GIF file)]


Table I.

Synthetic oligodeoxynucleotides used to generate ribozyme and antisense constructs


Rz1a 5' CTCggatcc<UNL>CCGTGGCTGTCTC</UNL>CTGATGAGTCCGAGAGGACGAA<UNL>ACTGCTGGGTGTG</UNL>ggatccGAG-3'
3' GAGcctaggGGCACCGACAGAGGACATCTCAGGCTCTCCTGCTTTGACGACCCACACcctaggCTC-5'
Rz2a 5' CTCggatccCACACCCAGCAGTTTCGTCCTCTCGGACTCATCAGGAGACAGCCACGGggatccGAC-3'
3' GAGcctaggGTGTGGGTCGTCAAAGCAGGAGAGCCTGAGTAGTCCTCTGTCGGTGCCcctaccCTC-5'
Rz13 5' agctt<UNL>CCGTGGCTGTCTC</UNL>CTGATGAGTCCGAGAGGACGAA<UNL>ACTGCTGGGTGTG</UNL>g-3'
3'      aGGCACCGACAGAGGACTACTCAGGCTCTCCTGCTTTGACGACCCACACcctag-5'
Rz9 5' agctt<UNL>GGCTGTCTC</UNL>CTGATGAGTCCGAGAGGACGAA<UNL>ACTGCTGGG</UNL>g-3'
3'      aCCGACAGAGGACTACTCAGGCTCTCCTGCTTTGACGACCCcctag-5'
antiPC 5' agctt<UNL>CCGTGGCTGTCTCGACTGCTGGGTGTG</UNL>g-3'
3'      aGGCACCGACAGAGCTGACGACCCACACcctag-5'
sRz 5' gatccGATACCCTGTCACCGGATGTGTTTTCCGGTCTGATGAGTCCGTGAGGACGAAACAGGACTGTCg-3'
3'      gCTATGGGACAGTGGCCTACACAAAAGGCCAGACTACTCAGGCACTCCTGCTTTGTCCTGACAGcttaa-5'
tT 5' aattcTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTGCgc-3'
3'      gATCGTATTGGGGAACCCCGGAGATTTGCCCAGAACTCCCCAAAAAACGcgccgg-5'

a  The same pair of oligonucleotides was used to clone Rz1 (sense orientation) and Rz2 (antisense orientation); lowercase sequences, restriction sites; underlined sequences, hybridization arms complementary to P/C mRNA; sRz, self-cleaving ribozyme cassette from sTobRSV, site of sTobRSV self-cleavage indicated in bold italics; tT, bacteriophage T7 RNA polymerase terminator sequences.


Fig. 1. Ribozyme target site. A, Sendai virus P/C mRNA with the site of ribozyme interaction (open box) enlarged. Cleavage site is indicated after base 71. The catalytic sequences of the hammerhead-type ribozyme, Rz1, from sTobRSV, flanked by 13 nucleotides complementary to bases 58-84 of the P/C mRNA are shown. The underlined sequences are present in Rz13 but are absent from Rz9 ribozymes. B, predicted secondary structure for the first 274 nt of the P/C mRNA. The region of ribozyme hybridization (single open triangles for Rz13 and double open triangles for Rz9) and the cleavage site (solid arrowhead) are shown. RNA folding was predicted by RNAFOLD software based on the algorithm of Zucker et al. (33). The free energy values (-kcal) for each stem-loop are given on the top. Asterisk indicates a highly folded structure beginning at nt 140 which was predicted not to interact with other areas of the substrate or with the ribozyme sequences. The last unpaired 5 bases of P274 (CUCGC) are difficult to read due to overlapping graphics generated by the RNAFOLD program.
[View Larger Version of this Image (16K GIF file)]


In addition to pcRz1 and pcRz2 several other ribozyme containing plasmids were constructed from oligonucleotides designated as Rz13, Rz9, and anti-PC (Table I). Upon annealing, these oligonucleotides formed duplexes with cohesive restriction sites at both termini for their directed ligation into the HindIII and BamHI (H/B) sites of pcDNAI/amp. Upon ligation of duplexes to pcDNAI/amp, the following plasmids were generated, pcRz13, pcRz9, and pcanti-PC (Fig. 2B). The antisense duplex (anti-PC) contained 27 nt complementary to the P/C mRNA from nt 58-84, without the catalytic core (Table I). Additional duplexes (Table I) were also synthesized which contained the sequences for a cis-acting self-cleaving hammerhead-type ribozyme (sRz = s) from sTobRSV and a T7 RNA polymerase transcription terminator (tT = t) (23). These duplexes were inserted downstream of the ribozyme and antisense duplexes in pcRz13, pcRz9, and pcanti-PC to generate the plasmids pcRZ13st, pcRz9st, and pcanti-PCst, respectively (Fig. 2C). Ribozymes were designated based on the structural characteristics of their HAL and NES (Table II). For example, Rz13B contains 13 nt of HAL and was generated from plasmid pcRz13 linearized at BamHI site.

Table II.

Characteristics of the P/C mRNA-specific ribozymes and antisense RNA and their predicted interactions

HAL, hybridization arm length; NES, nonhybridizing extraneous sequences. Free energy (Delta G) values were derived from predicted interactions using RNAFOLD analysis (Zucker et al. (33).)
Ribozyme HAL NES
R-R Delta G R-PT Delta Gb
5' 3'

nt nt -kcal/mol -kcal/mol
Rz1E 13 35 31 11.5 35.3
Rz13B 13 17 1 9.5 37.6
Rz13E 13 17 31 16.1 36.9
Rz13s (Rz13st)* 13 17 17 14.7 36.7
Rz9B 9 17 1 7.4 13.7
Rz9E 9 17 31 12.0 12.2
Rz9s (Rz9st)* 9 17 17 9.1 10.4
Anti-PCs (anti-PCst)* 26 17 17 7.5 44.5

a  Free energy of the <UNL>intra</UNL>molecular interactions (R-R) within the ribozyme transcripts.
b  Free energy of <UNL>inter</UNL>molecular interactions (R-S) between the hybridization arms and substrate (PT). Ribozymes denoted in parentheses by asterisks are the precursors of the corresponding ribozymes.

The full-length Sendai virus p/c gene cDNA was excised from the H/B sites of pg1f1/PC (24) and subcloned into the same sites in pcDNAI/amp to generate pcPC (Fig. 2D). All inserts were verified by restriction digestion and sequencing.

In Vitro Synthesis of RNAs

Ribozymes were synthesized using T7 RNA polymerase with MEGAscript or MEGAshortscript kits (Ambion) according to the supplier's protocols. Various sized ribozymes (Table II) were generated by run-off transcription from plasmids linearized at EcoRI (E) or BamHI (B) site or by transcription from supercoiled plasmid templates containing the self-cleaving ribozyme (sRz). The substrate molecule (P274) corresponding to the first 274 nt of the 5'-terminal region of the P/C mRNA was similarly synthesized from pcPC linearized at StyI site (Fig. 2D). Transcripts were labeled with a trace amount of [alpha -32P]UTP (25 pmol; 800 Ci/mmol) (Amersham Corp.), and their yields were determined by trichloroacetic acid precipitation on filter paper squares (25). The quality of RNA transcripts was assessed on denaturing polyacrylamide gels (data not shown). Since only the transcripts of the appropriate size were synthesized, no further purification was necessary.

Cleavage Reactions

Rate constants for the cleavage of P/C mRNA (P274) were determined under single turnover (STO) conditions with excess ribozyme or under multiple turnover (MTO) conditions with excess substrate. The STO reactions were performed using 2-10-fold molar excess of ribozyme. Substrate concentration [S] was kept at 80 nM while ribozyme concentrations [R] ranged from 160 to 800 nM. MTO reactions were performed with 5-20-fold molar excess of the substrate. [S] ranged from 50 to 200 nM with a constant [R] of 10 nM. Substrate and ribozyme transcripts were combined in cleavage buffer (50 mM Tris-Cl, pH 7.4 and 1 mM EDTA) and allowed to anneal for 5 min at 37 °C prior to initiation of the cleavage. An additional set of reactions was performed to determine the influence of preformed secondary structures on ribozyme activity. For these reactions, ribozyme (160 and 400 nM) and the substrate P274 (80 nM) were preincubated at 95 °C for 3 min and annealed by slowly (over 30 min) cooling to the reaction temperature of 37 °C. All cleavage reactions were initiated by adjusting the MgCl2 concentration to 20 mM and incubated at 37 °C in a total volume of 20-30 µl. Reactions were quenched at various times by mixing with an equal volume of stop solution (40 mM EDTA, 95% formamide, 0.05% bromphenol blue, 0.05% xylene cyanol) and then immediately frozen to -70 °C. Heat-denatured reaction products were resolved by denaturing polyacrylamide gel electrophoresis (PAGE) (8% polyacrylamide, 7 M urea) followed by autoradiography. The extent of substrate cleaved was quantified from autoradiographs scanned by a laser densitometer (Molecular Dynamics).

Initial cleavage rates (kobs) were determined from logarithmic plots of the fraction of substrate remaining (fracS) versus time during the earliest phase of the reactions when product formation was linear with time. For the STO reactions, several ribozyme concentrations [R] were used to obtain the pseudo-first order rate constants from Eadie-Hofstee plots of the kobs versus kobs/[R] (26) using a linear curve fit analysis (Kaleidagraph, Synergy Software). The "pseudo-Michaelis constant," (Km[high') and the initial cleavage rate (k2)values were obtained from the slope and Y intercept, respectively. Km[high' values describe the ribozyme concentration [R] at which the rate (k2 = Vmax) of the reaction is half-maximal (k2/2). The MTO constants were similarly obtained from Eadie-Hofstee plots of the initial velocity (nu ) versus (nu )/[S] (27, 28). Initial velocities were obtained from the early phase of the reactions when less than 10% of the substrate [S] had been converted to product. For the MTO reactions, the Km value reflects the substrate concentration [S] at which the reaction rate is half-maximal (Vmax/2).

Intracellular Expression of Ribozyme

CV-1 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum in a moist atmosphere with 5% CO2 at 37 °C in 35-mm dishes. Subconfluent CV-1 cells were infected at a multiplicity of infection of 5 with vTF7-3, a recombinant vaccinia virus that expresses T7 RNA polymerase in the cytoplasm of infected cells (29). Supercoiled pcPC was transfected alone or cotransfected with a 5-fold molar excess of linearized or supercoiled ribozyme (or antisense) plasmid (3 µg of pcPC and 15 µg of pcRz or pcanti-PC) using 10 µl/ml of Lipofectin (Life Technologies, Inc.). DNA-Lipofectin complexes were added to cells 30 min after vTF7-3 infection and incubated at 37 °C. At 14 h postinfection, cells were washed with phosphate-buffered saline containing Mg2+ and Ca2+ (phosphate-buffered saline+), and labeled with 100 µCi/ml 35S-Translabel (ICN) in methionine-free Dulbecco's modified Eagle's medium. After labeling for 4 h, cells were washed with phosphate-buffered saline(+) and lysed with 500 µl of RIPA buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.4, 2 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin, and 1 µg/ml leupeptin) (30). Nuclei and cellular debris were removed by pelleting at 15,000 × g for 25 min. Unless indicated otherwise, the P and C proteins were immunoprecipitated from 40 µl of lysate using polyclonal anti-P (31) and anti-C antisera (32) and resolved by SDS-PAGE. After electrophoresis the gels were dried and autoradiographed. Protein levels were quantified by densitometry scanning of the autoradiographs as described above. To control for variations due to transfection, P expression levels were compared with expression in pcPC alone and to pcRz2 and pcPC cotransfected cells. The transfection experiments were repeated three times, and statistical analysis (paired t test) was performed. As the level of C protein expression paralleled P protein expression, only the P quantifications are presented.

RNA Stability Assay

Gel-purified 32P-labeled ribozyme transcripts were subjected to RNase T2 digestion to determine the effect of the 3'-NES on ribozyme stability. Rz13B (1 nt 3'-NES), Rz13E (31 nt 3'-NES), and Rz13st (17 nt 3'-NES) were all synthesized in vitro as described above and purified from denaturing polyacrylamide gels. Appropriate RNA bands were sliced out from gels, and RNA was eluted by soaking gel pieces in diethyl pyrocarbonate/H2O containing 10 µg of tRNA at 37 °C for 12 h. The RNA was precipitated with EtOH, dried, and resuspended in 15 µl of diethyl pyrocarbonate/H2O. RNA was incubated in digestion buffer (50 mM Tris-Cl, pH 7.5, 1 mM MgCl2, and 0.003 unit of T2) for up to 60 min. Reactions were quenched by adding aliquots to an equal volume of the stop buffer as described above. Reaction products were resolved by denaturing PAGE and quantified by scanning densitometry of autoradiographs as described above. Reactions were performed two times with similar results.

RNA Secondary Structure Analysis

Secondary structures of the various ribozyme and substrate RNAs were predicted using RNAFOLD (version 2.0, Scientific & Educational Software). This software has been developed using the algorithm of Zuker et al. (33) and is based on physiological salt concentration. Ribozyme structures were modeled in the presence and absence of substrate, using the minimal target region (PT) sequences. To model the R-S interactions with RNAFOLD, substrate sequences were linked to ribozyme sequences with a spacing of 10 non-interacting bases. Similar hairpins were obtained when ribozyme and substrate RNAs were analyzed by alternate RNA folding programs.


RESULTS

Ribozyme Target Site in P/C mRNA

Our previous studies have shown that relatively low amounts of antisense oligonucleotides (50-100-fold molar excess over the mRNA) directed to the 5'-UTR of the P/C mRNA efficiently inhibited cell-free synthesis of all the P/C mRNA-encoded proteins (34). In addition, both the RNAFOLD predicted (Fig. 1B) and the experimental determination of the secondary structure (35) suggested that this region lacked strongly folded structures. Thus, we suspected this region of the 5'-UTR would be readily accessible for ribozyme interaction. To target this region, we constructed ribozymes containing the catalytic domain of sTobRSV (22) flanked by 18 (9-mer ribozymes) or 26 (13-mer ribozymes) nt complementary to the P/C mRNA at bases 62-80 and 58-84, respectively (Fig. 1A). The GUC cleavage site at nt 71 is located upstream of all the translation start sites (36). Thus, the cleavage at this site would abrogate the synthesis of all the p gene encoded proteins. Therefore, we targeted only one site for ribozyme interaction.

Ribozyme Structure

Several hammerhead ribozymes were compared to assess the influence of hybridization arm length (HAL) and nonhybridizing extraneous sequences (NES) on the cleavage of the substrate P274. Ribozymes contained HAL of 13 nt (% GC = 65) or 9 nt (% GC = 67) each with varying NES length (Figs. 2 and 3; Table II). NES are sequences transcribed along with the ribozyme which are not part of the hybridizing arms or the catalytic core. The NES for our ribozymes contained vector-derived sequences generated during run-off transcription of plasmids linearized at EcoRI site (E) (31 nt 3'-NES) or BamHI site (B) (1 nt 3'-NES) or contained sequences from intact plasmids containing the cis-acting self-cleaving ribozyme (sRz) and the T7 RNA polymerase terminator (tT) (designated as st; 17 nt 3'-NES). Although the efficacy of sRz self-cleavage in cells was not determined, efficient self-cleavage was observed in vitro especially when the sRz was upstream of the tT (data not shown).



Fig. 3. RNAFOLD predicted secondary structures for ribozyme (R-R) and ribozyme-substrate (R-S) interactions. Left panels present structures of ribozymes alone (R-R). Right panels represent the predicted interactions between the ribozyme and the substrate target region (PT). The target regions are indicated between the open triangles. Arrowhead points to the cleavage site, and the hybridization arms are marked by solid lines. A presents ribozymes synthesized from linearized plasmids at the indicated restriction sites (B = 1 and E = 31 nt of 3'-NES, 17 nt of 5'-NES for Rz13 and Rz9, and 35 nt for Rz1). B presents ribozyme and antisense transcripts containing the self-cleaving ribozyme (sRz) and T7 terminator (tT, in brackets). The site of self-cleavage is indicated by a small arrow. A large arrow denotes ribozyme putatively generated following self-cleavage by sRz (Rz13s, Rz9s, and anti-pCs). Predicted interactions between PT and Rz13s, Rz9s, and anti-PCs are also shown.
[View Larger Versions of these Images (22 + 26K GIF file)]


RNAFOLD predicted secondary structures for ribozyme RNA in the absence of substrate (left panel), and the structures predicted for the ribozyme-substrate interactions (R-S = r = PT) (right panel) are shown in Fig. 3, A and B. The structures of ribozymes (Rz13s and Rz9s) that would be putatively generated following self-cleavage of sRz from the larger precursors (Rz13st and Rz9st) are shown in Fig. 3B. Similarly, the predicted secondary structures of the antisense RNA molecules, anti-PCs, generated from the anti-PCst precursors are presented in Fig. 3B. The thermodynamic stabilities of the individual ribozymes and the ribozyme-substrate (R-S) complexes are presented in Table II.

Ribozyme Activity in Cell-free Reactions

For cell-free cleavage reactions to be predictive of intracellular ribozyme activity, they need to be conducted under conditions that approximate those found in vivo. However, in several previous studies, ribozyme and substrate RNAs were preincubated at high temperature and then snap-cooled or slowly cooled to reaction temperature. Elevated temperatures and pH and denaturants such as urea and formamide have all been used to enhance ribozyme activity. These conditions favor the formation of R-S duplexes by removing preformed intramolecular secondary structures. Since these situations would not be available intracellularly, we evaluated ribozyme activities under nearly physiological conditions as described under "Materials and Methods." All of the ribozymes cleaved the substrate (P274) yielding the expected sized products, P1 and P2 (Fig. 4). To determine the relative efficiencies of various ribozymes, rate constants for the cleavage of the substrate (P274) were determined under single turnover (STO) and multiple turnover (MTO) conditions (described below). Overall, the experimentally determined rate constants were consistent with the predicted secondary structures. The rate constants observed for the various ribozymes correlated with the thermal stabilities of their predicted secondary structure and with their predicted ability to interact with the substrate to form an active hammerhead complex (Fig. 3, right panel). In essence, ribozymes that were predicted by RNAFOLD to interact productively with the target region cleaved substrate more efficiently than those not predicted to interact productively.


Fig. 4. A representative autoradiograph of products of the P/C mRNA substrate (P274) cleaved by various ribozymes. 32P-Labeled substrate RNA (40 nM) comprising the first 274 nt of the P/C mRNA (S) was incubated at 37 °C in 50 mM Tris-Cl, pH 7.5, and 20 mM MgCl2 with each ribozyme (40 nM). At 60 min reactions were quenched with 40 mM EDTA and analyzed on an 8% polyacrylamide, M urea gel and autoradiographed. Substrate, S, (274 nt) and products, P1 (203 nt) and P2 (71 nt), are indicated. Ribozymes were synthesized from constructs that were linearized at EcoRI site (E = 31 nt 3'-NES) or BamHI site (B = 1 nt 3'-NES) (linear lanes). Ribozymes from supercoiled (SC lanes) plasmids containing a self-cleaving ribozyme and T7 RNA polymerase terminator (st = 17 nt 3'-NES following self-cleavage) were also used. Control reaction with an antisense RNA (from anti-PCB-) is also shown. Nucleic acid size markers are shown on the left that correspond to the labeled ribozyme bands visible in the gel.
[View Larger Version of this Image (67K GIF file)]


Single Turnover Kinetics

Rate constants were obtained under STO conditions from pseudo-first order reactions where ribozymes were in excess of the substrate (P274). In STO experiments, rate constants are derived from the first turnover, and therefore, they reflect the rate-determining step(s). Large differences in the initial cleavage rates (k2) were observed for ribozymes differing only in HAL and NES (described below). Since all the ribozymes had the same catalytic core and were targeted to the same site, the differences in initial cleavage rates most likely reflect the rate of R-S interaction and suggest the inherent ability of each ribozyme to interact with the substrate rather than the rate of chemical cleavage step (26).

Effect of HAL on Ribozyme Activity

To more accurately determine the influence of HAL (13 versus 9 nt) on ribozyme activity, we examined reaction kinetics of ribozymes with a minimum of NES (Rz13B versus Rz9B) under STO conditions. The initial cleavage rates (k2) differed by about 7-fold with Rz9B being less efficient (Table III). The lower efficiency of Rz9B compared with Rz13B was consistent with its lower energetic favorability for R-S interactions (Table II). The free energy (Delta G) of the R-S interactions for Rz13B (-37.6 kcal) was nearly 3-fold greater than that of the Rz9B (-13.7 kcal) (Table II). In addition, the RNAFOLD analysis indicated that intramolecular interactions (R-R) within the 9-mer ribozymes were more favorable than intermolecular interactions with the substrate (R-S) (Fig. 3A; Table II). Thus, the intramolecular interactions within the 9-mer ribozymes are more likely to interfere with the R-S interactions than those within 13-mer ribozymes. This observation could explain the differences in ribozyme activity. However, these predictions would need experimental validation.

Table III.

Single-turnover kinetics for Sendai virus P/C mRNA-specific ribozymes


Ribozyme k2a Km' k2/Km'a k2b k2/Km'b

min-1 nM min-1 µm-1 min-1 min-1 µm-1
Rz1E 0.16 797 0.20 ND ND
Rz13B 1.48 135 11 6.9 17
Rz13E 0.27 365 0.74 3.4 8.5
Rz13st 0.087 949 0.09 4.5 11
Rz9B 0.21 182 1.2 2.9 7
Rz9E 0.13 421 0.3 0.21 0.5
Rz9st 0.086 641 0.13 1.5 3.7

a  Single turnover kinetics measured with ribozyme [R] in excess of substrate (80 nM). Values obtained from Eadie-Hofstee plots of cleavage rates (kobs) versus kobs/[R] with [R] of 160, 320, 640 nM. kobs values were obtained from graphs of the ln fraction of substrate remaining (ln fracS) versus time as described in text.
b  Single turnover kinetics were determined following removal of preformed secondary structures by heat denaturation. Ribozyme (160 and 400 nM) and substrate (80 nM) were preincubated at 95 °C for 3 min and slowly cooled to reaction temperature of 37 °C prior to addition of MgCl2. ND, not determined.

Effect of NES on Ribozyme Activity

The computer-predicted folding patterns of Rz13 and Rz9 (Fig. 3) illustrate that ribozyme structures change depending on the extent of NES, which in turn may influence ribozyme activity. The influence of NES on ribozyme activity was determined by comparing the kinetics of ribozymes with varying NES length (Fig. 3). Under STO conditions, there was an apparent delay in the initiation of cleavage for all of the ribozymes relative to Rz13B (Fig. 5A). These delays resulted in large differences in the k2 values (Table III). The differences were greater among the 13-mer ribozymes than among the 9-mer ribozymes, probably due to the reduced efficiency of the 9-mer ribozymes. The k2 values for Rz13E, Rz1E, and Rz13st were 3-, 9-, and 15-fold, respectively, lower than Rz13B, whereas the k2 values among 9-mer ribozymes differed by about 2-fold. The k2 values were inversely related to Km[high' values, suggesting that the NES affect R-S interaction. The differences in catalytic efficiency (k2/Km[high') were even more pronounced, with Rz13B >100-fold more efficient than Rz13st (Table III). These results clearly suggest that the length and strength of the intramolecular interactions have a substantial effect on the R-S interaction. One explanation for this could be that the NES cause the ribozymes to adopt alternative secondary structures which may not allow ribozyme to readily interact with the substrate. Alternatively, the ribozymes may initially interact with the substrate (i.e. formation of one hybridization arm only) but must undergo a conformational change after binding to generate an active hammerhead complex.


Fig. 5. Ribozyme activity under single turnover (STO) conditions. 32P-Labeled substrate (P274, 80 nM) was incubated with 2-10-fold molar excess of ribozyme, without (-) and with (+) heat denaturation prior to annealing. All cleavage reactions were performed at 37 °C in 50 mM Tris-Cl, pH 7.4, and 20 mM MgCl2. A and B, ribozyme and substrate were annealed at 37 °C. Shown are representative plots of cleavage reactions performed with an 8-fold excess of ribozyme, ribozymes with 13-mer HAL (A) and 9-mer HAL (B). C and D, effect of heat denaturation of transcripts. Ribozyme and substrate were preincubated at 95 °C and annealed by slowly cooling to the reaction temperature of 37 °C. Shown are representative plots of reactions containing 5-fold excess ribozyme (400 nM), 13-mer ribozymes (C), and 9-mer ribozymes (D). Cleavage products (P) were quantified by scanning densitometry of autoradiographs and plotted as fraction of substrate remaining (fracS) versus time.
[View Larger Version of this Image (24K GIF file)]


To determine whether preformed structures within the ribozymes (R-R) hindered the R-S interactions, ribozyme and substrate RNAs were heat-denatured prior to annealing and allowed to cool slowly to 37 °C. This step was presumed to remove most of the secondary structures within the RNAs and allow the most energetically favored intramolecular (R-R) as well as intermolecular (R-S) interactions to occur. Following heat denaturation and slow renaturation, dramatic increases in initial cleavage rates and efficiencies were observed for most of the ribozymes (Table III). Interestingly, the magnitude of the increases correlated with the strength of the structural elements predicted to exist in the 3'-NES of the ribozymes (Fig. 3, left panel; Table II). Cleavage efficiency (k2/Km[high') increased by ~12- and ~100-fold for Rz13E and Rz13st, respectively, whereas the efficiency of Rz13B increased only marginally. Under these conditions the catalytic efficiencies of the various 13-mer ribozymes were essentially the same. Heat denaturation also increased the cleavage rates for the 9-mer ribozymes, Rz9B and Rz9st, but not Rz9E (Table III). Curiously, cleavage by Rz9E remained relatively linear compared with the other ribozymes (Fig. 5B). These results suggested that the R-R interactions within Rz9E may be in equilibrium with the R-S interactions.

After the initial burst of cleavage, there was a second slower phase of continuing cleavage with the other ribozymes, except Rz13B. This observation suggested that more than one ribozyme conformation may form following renaturation and presumably during transcription. It is likely, therefore, that additional ribozyme conformations exist in RNA solutions and that some may have suboptimal activity. Therefore, the delay in the initial cleavage rates relative to Rz13 are probably due to the time required to acquire necessary conformational changes to form an active hammerhead complex with the substrate.

Multiple Turnover Kinetics

MTO reactions were performed with 5-20-fold molar excess of the substrate (P274) to determine the efficiency of ribozyme turnover. Initial velocities were determined during the earliest phase of the reactions when the rate of the substrate cleavage was linear with time. Consistent with the Michaelis-Menten model for enzyme kinetics (27), initial velocities increased as substrate concentration [S] increased. Turnover numbers (kcat) for the various ribozymes were relatively low and ranged from 0.004 to 0.025 per min, the lowest being for the ribozyme, Rz13E (Table IV). Km values on the other hand varied by more than 15-fold (22-395 nM). Consistent with the STO reactions, the Km values increased in direct proportion to the complexity of the predicted secondary structures within the 3'-NES of the ribozymes (Fig. 3). The increases in Km values were also accompanied by decreases in the catalytic efficiencies (kcat/Km). The ribozymes Rz13E and Rz13st showed 40- and 25-fold lower kcat/Km values, respectively, than Rz13B which lacked 3'-secondary structure (Fig. 3). The catalytic efficiencies of the 9-mer ribozymes differed by ~10-fold, and the values were related to their Km values as observed for 13-mer ribozymes. Because Km values reflect the ability of enzyme and substrate to interact, these results further suggest that the presence of NES slowed the rate of association between the ribozyme and substrate (R-S). These observations further indicated that the NES have a rate-determining effect on ribozyme efficiency and that the rate-limiting step in these reactions was the R-S association.

Table IV.

Multiple turnover kinetics for Sendai virus P/C mRNA-specific ribozymes

Multiple turnover kinetics were measured with substrate in excess of ribozyme. Substrate concentrations [S] ranged from 50 to 200 nM with ribozyme concentration kept at 10 nM.
Ribozyme kcat Km kcat/Km

min-1 nM µm-1 min-1
Rz1Ea 0.008 58 0.14
Rz13B 0.025 22 1.1
Rz13E 0.004 107 0.028
Rz13st 0.013 289 0.045
Rz9B 0.013 37 0.35
Rz9E 0.022 395 0.055
Rz9st 0.011 133 0.082

a  [R] at 20 nM. Values were obtained from Eadie-Hofstee plots of cleavage velocity (nu ) versus nu /[S].

On the other hand, while the intramolecular interactions within the ribozymes may hinder R-S interaction, they could also enhance turnover. Intramolecular interactions may help to increase turnover by destabilizing the intermolecular interaction between ribozyme and substrate. Due to the length of the hybridization arms (9 or 13 nt each) and rather high binding energy between the ribozyme and substrate (Table II), high catalytic turnover was not expected for these ribozymes. However, all of the ribozymes cleaved more than 1 eq of substrate and so were truly catalytic (Fig. 6).


Fig. 6. Comparison of ribozyme activity under MTO conditions. Ribozymes (10 nM) were combined with excess 32P-labeled substrate (P274 at 50, 100, and 200 nM). Representative plots of reactions containing 20-fold excess substrate are shown. Cleavage products (P) were quantified by scanning densitometry of autoradiographs as described above and plotted relative to ribozyme concentration (P/R) as a function of time. A, 13-mer ribozymes; B, 9-mer ribozymes.
[View Larger Version of this Image (17K GIF file)]


In sum, the k2 values from the STO reactions (Table III) were much more rapid than the kcat values derived from MTO reactions (Table IV) for the same ribozymes. The initial cleavage rates (k2) obtained under excess ribozyme conditions reflect the rate-determining step(s) prior to product release, whereas the kcat values represent the rates of all phases of the reaction (27). Thus, the low kcat values appear to be due to a slow product release step. The kcat and k2 values will be equivalent only if the binding steps (association and dissociation) were much faster than the cleavage step of the reactions (27). The observation made with the STO reactions that ribozyme structural elements affected its efficiency was also borne out by the MTO reactions. The rate constants observed for Rz13B (Tables III and IV) were comparable with the kcat and Km values reported for similar types of ribozymes (19, 28, 37, 38), suggesting the general validity of our observations.

Ribozyme-mediated Inhibition of P and C Protein Expression in CV-1 Cells

To determine the intracellular efficacy of ribozymes, pcPC and pcRz constructs were cotransfected (at a molar ratio of 1:5) into CV-1 cells that had been previously infected with the recombinant vaccinia virus, vTF7-3. vTF7-3 expresses T7 RNA polymerase in the cytoplasm (29) of the infected cells. We chose this system because both P/C mRNA and ribozymes would be expressed in the cytoplasm where Sendai virus replication naturally occurs. Ribozyme constructs were transfected after linearization at BamHI site (B) or EcoRI site (E) or transfected as intact circular/supercoiled molecules. Similarly, antisense constructs were also cotransfected with pcPC to determine whether the intracellular ribozymes were more efficient than antisense RNAs. With this system, transfected ribozyme and antisense constructs would generate transcripts identical to the RNA molecules synthesized in vitro. Therefore, a correlation was expected between in vitro cleavage results and the inhibition of p gene expression in cells.

The in vitro results in conjunction with RNAFOLD analysis of the 9-mer and 13-mer ribozymes indicated that the 13-mer constructs would be more effective in vivo. This was essentially the case as the 9-mer ribozymes were relatively inert in transiently transfected cells compared with the 13-mer ribozymes (Fig. 7).


Fig. 7. Ribozyme-mediated inhibition of P and C protein expression in transiently transfected cells. Supercoiled pcPC was cotransfected with a 5-fold molar excess of either linearized (linear lanes) or supercoiled (SC lanes) ribozyme constructs into CV-1 cells infected with vTF7-3 at a multiplicity of infection of 5. Ribozymes and antisense RNA designations are as described in Fig. 4. The P and C proteins were immunoprecipitated with polyclonal anti-P and anti-C antisera and resolved by 12% SDS-PAGE as described in the text. A, autoradiograph from cotransfections. The lane labeled P (-) denotes pcPC transfection alone (without ribozyme), and Rz2E (-) represents pcPC cotransfection with the antisense ribozyme (negative control), as described in the text. Proteins of unknown origin (cellular or vaccinia virus) which nonspecifically precipitate with the polyclonal antisera are present between the P and C. B, relative level of P expressed with and without ribozyme or antisense constructs. Transfections were repeated 3 times with their mean and standard deviation shown. *p < 0.0002 and **p < 0.05 as determined by the paired t test.
[View Larger Version of this Image (52K GIF file)]


To evaluate the effect of NES on the intracellular ribozyme activity, we compared ribozymes with variable NES length. To determine the influence of 5'-NES, we examined ribozymes with 35 nt (Rz1E) and 17 nt (Rz13E) of 5'-NES. Rz13E was 20% more effective in inhibiting p gene expression than Rz1E (Fig. 7). Plasmids were also linearized at different restriction sites which on expression in cells yielded variable lengths of 3'-NES. Contrary to the cell-free results, none of the constructs with 1 nt of 3'-NES (Rz13B, Rz9B, or anti-PCB) were effective in cells. The extra 31 nt on the 3'-termini of Rz13E and anti-PCE (but not Rz9E) enhanced activity in cells (~50% inhibition of P expression), perhaps by rendering these transcripts more resistant to intracellular nucleases.

As an alternative to linearizing plasmids to control the length of 3'-NES, we incorporated a cis-acting self-cleaving ribozyme (sRz) and a T7 terminator (tT) into the ribozyme constructs (Fig. 2). Because these constructs were intact supercoiled molecules, they had increased transfection efficiency over linear plasmids.2 In addition, it has been observed that transcription by T7 RNA polymerase is up to 10-fold more efficient with intact than with linear plasmids (39). As expected, expression of ribozymes (and antisense RNAs) from these intact constructs resulted in substantially more inhibition of p gene expression in cells. Rz13st and anti-PCst inhibited P/C expression by about 70% in transfected cells (Fig. 7B), whereas supercoiled ribozyme constructs without these cassettes had no detectable effect on P/C expression (data not shown). Clearly, the incorporation of the sRz and tT cassettes into the constructs resulted in increased effectiveness of the T7 expression system and the increased efficiency of ribozyme- and antisense-mediated inhibition of p gene expression.

To determine the ratio of ribozyme to P/C mRNA necessary for efficient intracellular ribozyme activity, plasmids (pcRz13st, pcanti-PCst, and pcPC) were cotransfected at R:S molar ratios of 1:1, 2.5:1, 5:1, 10:1, or 20:1. However, the ratio of the intracellular ribozyme and substrate is only implied. While efficient inhibition of P protein expression was observed when pcRz13st and pcanti-PCst were cotransfected with pcPC at a 5:1 R:S ratio (Figs. 7 and 8), at R:S ratios of 2.5:1 much less of an effect was seen, especially for the antisense construct (Fig. 8). Increasing the molar ratio of R-S to 10:1 and 20:1 resulted in increasing the inhibition of P/C expression to about 95% (Fig. 8). For these transfections 5-fold more lysate was required to detect the P protein at the 20:1 R:S ratio (Fig. 8B). The reduced activity observed at the low R:S ratios could be explained by the Poisson distribution of the transfected plasmids into cells. Overall, the results showed that both Rz13st and anti-PCst inhibited the expression of P and C proteins with approximately equal efficiency, albeit at the higher R:S ratio. Nonetheless, the effect of the ribozyme was about 20% greater than the antisense RNA (Fig. 8B) at the lower R:S ratio. In addition, the dose-response relationship indicated that the inhibition of p gene expression was due to ribozyme or antisense activity and not due to other factors such as transfection efficiency.


Fig. 8. Dose-response relationship of ribozyme and antisense RNA activity in transiently transfected cells. pcPC (3 µg) was cotransfected with 2.5-20-fold molar excess of Rz13st and anti-PCst constructs and analyzed as described in Fig. 7. A, autoradiograph of cotransfections with P and C proteins indicated. The asterisk indicates a cellular or viral protein which was immunoprecipitated by the polyclonal anti-P or anti-C sera as described in Fig. 7. B, relative level of P compared with pcPC alone (-) or pcPC cotransfected with negative control, pcRz2.
[View Larger Version of this Image (54K GIF file)]


Stability of Ribozyme RNA

We alluded previously that NES may help to stabilize ribozymes. To test this directly, gel-purified 32P-labeled ribozyme transcripts Rz13B (1 nt 3'-NES), Rz13E (31 nt 3'-NES), and Rz13s (17 nt 3'-NES, following self-cleavage of precursor Rz13st) were incubated with a single strand-specific ribonuclease, RNase T2, to determine the effect of 3'-NES on RNA stability (all of these ribozymes had identical 5'-NES). Ribozyme bands were purified to separate Rz13s from the precursor Rz13st and the products generated following self-cleavage of sRz. All ribozymes were purified to ensure similar treatment for each transcript. Rz13s was shown to be 8-fold more resistant to nuclease digestion than Rz13B and about 3-fold more resistant than Rz13E. Rz13E was also almost three times more stable than Rz13B (Fig. 9). RNAFOLD analysis predicted that the 3'-termini of Rz13E and to a greater extent Rz13st would fold into relatively stable stem-loop structures (Fig. 3, left panel). Thus, these results suggest that ribozymes whose termini are predicted to contain stable secondary structures have a better chance to survive and act in the cellular milieu.


Fig. 9. Ribozyme stability assay. 32P-Labeled ribozymes: Rz13B (1 nt 3'-NES), Rz13E (31 nt 3'-NES), or Rz13s (17 nt 3'-NES) were incubated with 0.003 unit of RNase T2 for 60 min. The fraction of each ribozyme (fracR) resistant to RNase T2 digestion was determined by scanning densitometry of autoradiographs following polyacrylamide gel electrophoresis as described under "Materials and Methods." The half-life (t1/2) of each ribozyme is shown.
[View Larger Version of this Image (20K GIF file)]



DISCUSSION

To create effective intracellular ribozymes targeted to the Sendai virus P/C mRNA, critical parameters that influence ribozyme efficiency were examined. Use of cell-free cleavage reactions and a vaccinia virus-T7 RNA polymerase expression system (29) enabled us to analyze several ribozymes. With this system the ability of a ribozyme to interact with the substrate in the complex milieu of the cytoplasm can be determined rather quickly. The benefits of this system for ribozyme analysis have been previously described (19). In vitro assays to optimize ribozymes for intracellular use have often produced inconsistent results. For the current study cell-free cleavage assays were performed under physiological conditions of temperature and pH with ribozyme transcripts which were representative of those that would be generated in vivo. Under these conditions in vitro kinetics were generally consistent with the intracellular results. Significantly, the experimental results were consistent with the computer-generated secondary structure predictions. This suggests that structural analyses when combined with experimental analysis should prove useful for designing effective intracellular ribozymes.

Accessibility of the target site (19, 28, 40), the length of hybridization arms (HAL) (26, 37, 41, 42), and the extent of nonhybridizing extraneous sequences (NES) (9, 19, 22, 43) are some of the parameters that can affect the interaction between the ribozyme and the substrate. As predicted from our previous studies (34, 35), the targeted cleavage site in the 5'-UTR was shown to be accessible to all of the ribozymes examined. In addition, all ribozymes exhibited catalytic activity, cleaving more than one molecule of substrate per molecule of ribozyme. However, large differences in catalytic efficiency were found between ribozymes differing only in their HAL and NES. Differences in ribozyme activity were consistent with the RNAFOLD-predicted ability of the ribozymes to interact with the substrate. Both the kinetic data and intracellular results suggest that HAL and NES of the P/C-specific ribozymes modulated ribozyme-substrate interaction in a rate-determining manner.

Hybridization arm length (HAL) can have a significant effect on ribozyme activity, not only by providing specificity but also by determining the dynamics of the R-S interaction. In vitro kinetic studies have suggested that hammerhead ribozymes with hybridization arms >5 nt are limited by their ability to dissociate from their substrate (26, 41). Consequently, long hybridization arms could inhibit ribozyme turnover. Reducing the hybridization arm length which subsequently reduces the binding energy (Delta G) between the R-S interaction should promote better release of ribozymes. However, this could also diminish the potential association between the ribozyme and substrate, which appears to be the rate-limiting step in the cleavage of long substrates (22, 37, 38). Ribozymes with shorter arms are also more likely to have reduced intracellular specificity.

We generated ribozymes with 9-mer hybridization arms to increase turnover. However, these constructs failed to increase ribozyme activity when compared with the 13-mer armed ribozymes in cell-free assays. RNAFOLD analysis predicted that the intramolecular interactions (R-R) of the Rz9 were energetically more favorable than the intermolecular interactions (R-S) between the ribozyme and the substrate (Fig. 3). These results suggest that the free energy (Delta G) of the interaction between the 9-nt hybridization arms and the substrate may be insufficient to melt the native intramolecular structures. Thus, the 9-mer ribozymes proved to be ineffective most likely due to their inability to associate with the substrate.

Intracellular expression of ribozymes via eukaryotic vectors results in changes to the basic ribozyme structure due to incorporation of the vector-derived sequences (or NES). Previous studies have demonstrated that additional sequences can increase stability of the ribozymes against cellular nucleases (44, 45). On the other hand, these sequences could also reduce the ability of a ribozyme to interact productively with the substrate (17-20). Since we introduced ribozymes into cells using a T7 expression system, we also examined the influence of these extraneous vector-derived sequences on ribozyme activity. Cell-free assays demonstrated that ribozyme efficiency increased as the length and the complexity of the nonhybridizing vector-derived sequences (NES) were reduced (Table III). In contrast, the constructs linearized at BamHI, which contained minimal 3'-NES (1 nt 3'-NES; Fig. 3A), were essentially inert intracellularly. These results imply that NES may be necessary to protect the ribozymes from intracellular nucleases. However, as the extended 5'-NES (35 nt of Rz1E) reduced ribozyme activity, judicious use of extraneous sequences will be necessary for generating effective ribozymes.

The most effective intracellular ribozyme (Rz13st) contained the sRz and tT cassettes, which upon self-cleavage generated a ribozyme (Rz13s) with 17 nt each of 5'- and 3'-NES. Both 17 nt termini were predicted by RNAFOLD to form stem-loop structures (Fig. 3). Although the secondary structure of the RNA has not been determined experimentally, it was shown that its stability was consistent with the RNAFOLD analysis. The half-life of Rz13s in the presence of RNase T2 was about 8-fold longer than Rz13B (without structure) and about 3-fold longer than Rz13E (with weaker stem-loop). These results are also consistent with previous studies showing that stem-loop structures can increase RNA half-life (44, 46). The presence of preformed secondary structures in Rz13s was further suggested by the 100-fold increase in cleavage activity following heat denaturation prior to annealing (Table IV). Thus, the increase in intracellular activity of Rz13s (and anti-PCs) is most likely related to its increased stability due the presence of the predicted stem-loop structures at their termini. In addition, self-cleavage by the cis-acting ribozyme (sRz) in these constructs results in a 3'-termini containing a 2',3'-cyclic phosphate (22), which could further enhance RNA stability by protecting the transcripts from 3'-exonuclease digestion. The increased activity with Rz13s and anti-PCs could be due to increased efficiency of the R-S interaction. It is plausible that the stem-loops could also sequester the terminal NES into defined structures which would subsequently limit their nonproductive interactions with other areas of the substrate. Although our studies indicated that ribozymes behaved intracellularly, as expected, we have no direct evidence that they indeed cleaved the substrate.

Both the ribozyme (Rz13s) and antisense RNAs (anti-PCs) were able to successfully inhibit p gene expression in transiently transfected cells. However, based on the predicted secondary structures combined with the cell-free and intracellular assays, ribozyme activity appears to be limited by the rate of ribozyme-substrate interaction, rather than turnover efficiency. This brings up the question whether the ribozymes provide an advantage over antisense RNAs. At higher intracellular R:S ratios (10:1 and 20:1), there is no obvious advantage for ribozyme activity. However, at the lower R:S ratios (2.5:1 and 5:1) Rz13s was slightly more effective than anti-PCs. This indicates that addition of catalytic sequences to antisense RNA imparts an advantage where recycling of ribozyme is possible. However, even in the absence of efficient turnover, the irreversible nature of the trans-cleavage reaction would make ribozyme more desirable than antisense RNA alone. Unquestionably, all these presumptions have to be experimentally tested.

In conclusion, our results suggest that appropriate sized ribozymes (or antisense RNAs) with nuclease-resistant structures at their 3'- and 5'-termini can serve as effective modulators of gene expression.


FOOTNOTES

*   This work was supported by Research Grant AI30517 from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Portions of this work will be submitted in partial fulfillment of the requirements for the Ph.D. degree from the Graduate College of Rush University. Present address: Gene Therapy Center, University of North Carolina, Chapel Hill, NC 23599.
§   To whom correspondence should be addressed: Dept. of Immunology/Microbiology, Rush Medical College, 1653 West Congress Pkwy., Chicago, IL 60612. Tel.: 312-942-7768; Fax: 312-226-6020.
1    The abbreviations used are: HAL, hybridization arm length; NES, nonhybridizing extraneous sequences; STO, single turnover; MTO, multiple turnover; UTR, untranslated region; nt, nucleotide(s); PAGE, polyacrylamide gel electrophoresis; sTobRSV, satellite RNA of tobacco ring spot virus; sRz, self-cleaving ribozyme; tT, transcription terminator.
2    D. K. Gavin and K. C. Gupta, unpublished results.

REFERENCES

  1. Kingsbury, D. W. (1991) in Fundamental Virology (Fields, B. N., and Knipe, D. M., eds), pp. 507-524, Raven Press, Ltd., New York
  2. Vidal, S., Curran, J., and Kolakofsky, D. (1990) EMBO J. 9, 2017-2022 [Abstract]
  3. Dillon, P. J., and Gupta, K. C. (1989) J. Virol. 63, 974-977 [Medline] [Order article via Infotrieve]
  4. Portner, A., Gupta, K. C., Seyer, J. M., Beachey, E. H., and Kingsbury, D. W. (1986) Virus Res. 6, 109-121 [CrossRef][Medline] [Order article via Infotrieve]
  5. Horikami, S. M., Curran, J., Kolakofsky, D., and Moyer, S. A. (1992) J. Virol. 66, 4901-4908 [Abstract]
  6. Curran, J., Marq, J. B., and Kolakofsky, D. (1992) Virology 189, 647-656 [Medline] [Order article via Infotrieve]
  7. Cech, T. R. (1987) Science 236, 1532-1539 [Medline] [Order article via Infotrieve]
  8. Uhlenbeck, O. C. (1987) Nature 328, 596-600 [CrossRef][Medline] [Order article via Infotrieve]
  9. Haseloff, J., and Gerlach, W. L. (1988) Nature 334, 585-591 [CrossRef][Medline] [Order article via Infotrieve]
  10. Sarver, N., Cantin, E. M., Chang, P. S., Zaia, J. A., Ladne, P. A., Stephens, D. A., and Rossi, J. J. (1990) Science 247, 1222-1225 [Medline] [Order article via Infotrieve]
  11. Dropulic, B., Lin, N. H., Martin, M. A., and Jeang, K.-T. (1992) J. Virol. 66, 1432-1441 [Abstract]
  12. Ojwang, J. O., Hampel, A., Looney, D. J., Wong-Staal, F., and Rappaport, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10802-10806 [Abstract]
  13. Xing, Z., and Whitton, J. L. (1993) J. Virol. 67, 1840-1847 [Abstract]
  14. Cantor, G. H., McElwain, T. F., Birkebak, T. A., and Palmer, G. H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10932-10936 [Abstract]
  15. Scanlon, K. J., Ishida, H., and Kashani-Sabet, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11123-11127 [Abstract/Free Full Text]
  16. Efrat, S., Leiser, M., Wu, Y. J., Fusco-DeMane, D., Emran, O. A., Surana, M., Jetton, T. L., Magnuson, M. A., Weir, G., and Fleischer, N. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2051-2055 [Abstract]
  17. Cotten, M., and Birnstiel, M. L. (1989) EMBO J. 8, 3861-3866 [Abstract]
  18. Cameron, F. H., and Jennings, P. A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 9139-9143 [Abstract]
  19. L'Huillier, P. J., Davis, S. R., and Bellamy, A. R. (1992) EMBO J. 11, 4411-4418 [Abstract]
  20. Perriman, R., Graf, L., and Gerlach, W. L. (1993) Antisense Res. Dev. 3, 253-263 [Medline] [Order article via Infotrieve]
  21. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  22. Forster, A. C., and Symons, R. H. (1987) Cell 49, 211-220 [Medline] [Order article via Infotrieve]
  23. Rosenberg, A. H., Lade, B. N., Chui, D. S., Lin, S. W., Dunn, J. J., and Studier, F. W. (1987) Gene (Amst.) 56, 125-135 [CrossRef][Medline] [Order article via Infotrieve]
  24. Patwardhan, S., and Gupta, K. C. (1988) J. Biol. Chem. 263, 4907-4913 [Abstract/Free Full Text]
  25. Gupta, K. C. (1992) BioTechniques 12, 226-228 [Medline] [Order article via Infotrieve]
  26. Fedor, M. J., and Uhlenbeck, O. C. (1992) Biochemistry 31, 12042-12054 [Medline] [Order article via Infotrieve]
  27. Fersht, A. (1985) Enzyme Structure and Mechanism, W. H. Freeman & Co., New York
  28. Fedor, M. J., and Uhlenbeck, O. C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1668-1672 [Abstract]
  29. Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 8122-8126 [Abstract]
  30. Mehdi, H., Ono, E., and Gupta, K. C. (1990) Gene (Amst.) 91, 173-178 [Medline] [Order article via Infotrieve]
  31. Byrappa, S., Hendricks, D. D., Pan, Y.-B., Seyer, J. M., and Gupta, K. C. (1995) Virology 208, 408-413 [CrossRef][Medline] [Order article via Infotrieve]
  32. Hendricks, D. D., Ono, E., Seyer, J. M., and Gupta, K. C. (1993) Virology 197, 471-474 [CrossRef][Medline] [Order article via Infotrieve]
  33. Zuker, M., Jaeger, J. A., and Turner, D. H. (1991) Nucleic Acids Res. 19, 2707-2714 [Abstract]
  34. Gupta, K. C. (1987) J. Biol. Chem. 262, 7492-7496 [Abstract/Free Full Text]
  35. Gupta, K. C., Ono, E., and Xu, X. (1996) Biochemistry 35, 1223-1231 [CrossRef][Medline] [Order article via Infotrieve]
  36. Gupta, K. C., and Patwardhan, S. (1988) J. Biol. Chem. 263, 8553-8556 [Abstract/Free Full Text]
  37. Heidenreich, O., and Eckstein, F. (1992) J. Biol. Chem. 267, 1904-1909 [Abstract/Free Full Text]
  38. Denman, R. B. (1993) Nucleic Acids Res. 21, 4119-4125 [Abstract]
  39. Taira, K., Nakagawa, K., Nishikawa, S., and Furukawa, K. (1991) Nucleic Acids Res. 19, 5125-5130 [Abstract]
  40. Xing, Z., and Whitton, J. L. (1992) J. Virol. 66, 1361-1369 [Abstract]
  41. Goodchild, J., and Kohli, V. (1991) Arch. Biochem. Biophys. 284, 386-391 [Medline] [Order article via Infotrieve]
  42. Herschlag, D. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6921-6925 [Abstract]
  43. Chowrira, B. M., Pavco, P. A., and McSwiggen, J. A. (1994) J. Biol. Chem. 269, 25856-25864 [Abstract/Free Full Text]
  44. Sioud, M., Opstad, A., Zhao, J. Q., Levitz, R., Benham, C., and Drlica, K. (1994) Nucleic Acids Res. 22, 5571-5575 [Abstract]
  45. Lee, S. W., Gallardo, H. F., Gaspar, O., Smith, C., and Gilboa, E. (1995) Gene Ther. 2, 377-384 [Medline] [Order article via Infotrieve]
  46. Fuerst, T. R., and Moss, B. (1989) J. Mol. Biol. 206, 333-348 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.




This Article
Abstract
Full Text (PDF)
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Gavin, D. K.
Articles by Gupta, K. C.
Articles citing this Article
PubMed
PubMed Citation
Articles by Gavin, D. K.
Articles by Gupta, K. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.